62 related articles for article (PubMed ID: 30868858)
1. Clinical Performance of SurePath™ Preservative Compared to PreservCyt® with Cobas® and Hybrid Capture® 2 HPV Tests in a Colposcopy Population.
Pyne MT; Tardif KD; Allen A; Sexsmith C; Lesher L; Adelman M; Janát-Amsbury MM; Schlaberg R
Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868858
[TBL] [Abstract][Full Text] [Related]
2. Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests.
Tardif KD; Pyne MT; Malmberg E; Lunt TC; Schlaberg R
PLoS One; 2016; 11(2):e0149611. PubMed ID: 26905067
[TBL] [Abstract][Full Text] [Related]
3. Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens.
Chernesky M; Jang D; Escott N; Gilchrist J; Li J; Elit L; Lytwyn A; Smieja M; Ratnam S; Arias M; Getman D; Weinbaum B; Kirkconnell B; Dockter J
Papillomavirus Res; 2017 Jun; 3():155-159. PubMed ID: 28720450
[TBL] [Abstract][Full Text] [Related]
4. Performance of the cobas HPV Test for the Triage of Atypical Squamous Cells of Undetermined Significance Cytology in Cervical Specimens Collected in SurePath.
Tewari D; Novak-Weekley S; Hong C; Aslam S; Behrens CM
Am J Clin Pathol; 2017 Nov; 148(5):450-457. PubMed ID: 29045515
[TBL] [Abstract][Full Text] [Related]
5. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
6. Comparison of human papillomavirus detection by Aptima HPV and cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology.
Castle PE; Eaton B; Reid J; Getman D; Dockter J
J Clin Microbiol; 2015 Apr; 53(4):1277-81. PubMed ID: 25653409
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Preanalytic Procedure for Performing the cobas HPV Test in SurePath Preservative Fluid.
Krevolin MD; Hardy D; Pane J; Aslam S; Behrens CM
J Mol Diagn; 2017 Mar; 19(2):288-294. PubMed ID: 28041871
[TBL] [Abstract][Full Text] [Related]
8. A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population-PREDICTORS 4.
Cuzick J; Ahmad AS; Austin J; Cadman L; Ho L; Terry G; Kleeman M; Ashdown-Barr L; Lyons D; Stoler M; Szarewski A
J Clin Virol; 2016 Sep; 82():145-151. PubMed ID: 27498250
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.
Levi AW; Bernstein JI; Hui P; Duch K; Schofield K; Chhieng DC
Arch Pathol Lab Med; 2016 Feb; 140(2):153-7. PubMed ID: 26910220
[TBL] [Abstract][Full Text] [Related]
10. Transition from Hybrid Capture 2 to Cobas 4800 in Hpv detection: sensitivity and specificity for Cin2+ in two time periods.
Bottari F; Boveri S; Iacobone AD; Gulmini C; Igidbashian S; Cassatella MC; Landoni F; Sandri MT
Infect Dis (Lond); 2018 Jul; 50(7):554-559. PubMed ID: 29463149
[TBL] [Abstract][Full Text] [Related]
11. HPV testing by cobas HPV test in a population from Catalonia.
Lloveras B; Gomez S; Alameda F; Bellosillo B; Mojal S; Muset M; Parra M; Palomares JC; Serrano S
PLoS One; 2013; 8(3):e58153. PubMed ID: 23483984
[TBL] [Abstract][Full Text] [Related]
12. Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes.
Lindemann ML; Dominguez MJ; de Antonio JC; Sandri MT; Tricca A; Sideri M; Khiri H; Ravet S; Boyle S; Aldrich C; Halfon P
J Mol Diagn; 2012 Jan; 14(1):65-70. PubMed ID: 22079749
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay.
Catarino R; Vassilakos P; Bilancioni A; Bougel S; Boukrid M; Meyer-Hamme U; Petignat P
PLoS One; 2017; 12(7):e0181905. PubMed ID: 28750015
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of a prototype real-time PCR assay for the separate detection of human papilloma virus genotypes 16 and 18 and other high risk human papillomavirus in cervical cancer screening].
Mateos ML; Chacón de Antonio J; Rodríguez-Domínguez M; Sanz I; Rubio MD
Enferm Infecc Microbiol Clin; 2011; 29(6):411-4. PubMed ID: 21435749
[TBL] [Abstract][Full Text] [Related]
15. SurePath Specimens Versus ThinPrep Specimen Types on the COBAS 4800 Platform: High-Risk HPV Status and Cytology Correlation in an Ethnically Diverse Bronx Population.
Naeem RC; Goldstein DY; Einstein MH; Ramos Rivera G; Schlesinger K; Khader SN; Suhrland M; Fox AS
Lab Med; 2017 Aug; 48(3):207-213. PubMed ID: 28379422
[TBL] [Abstract][Full Text] [Related]
16. Clinical performance of the Cobas 4800 HPV test and the Aptima HPV assay in the management of women referred to colposcopy with minor cytological abnormalities.
Tewari P; White C; Kelly L; Pilkington L; Keegan H; D'Arcy T; Toole SO; Sharp L; O'Leary JJ; Martin CM
Diagn Cytopathol; 2018 Dec; 46(12):987-992. PubMed ID: 30284405
[TBL] [Abstract][Full Text] [Related]
17. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid.
Rabaan AA; Alfaraj SA; Alkhalifah MA
J Med Microbiol; 2018 May; 67(5):676-680. PubMed ID: 29580367
[No Abstract] [Full Text] [Related]
19. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
20. Aptima HPV Assay versus Hybrid Capture
Cook DA; Smith LW; Law J; Mei W; van Niekerk DJ; Ceballos K; Gondara L; Franco EL; Coldman AJ; Ogilvie GS; Jang D; Chernesky M; Krajden M
J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
